58 Results for "

FXa

" in MedChemExpress (MCE) Product Catalog:
Products (58)

58 Results for "FXa" in MCE Product Catalog:

19
19 Cited Publications
Referencia número: HY-50903
No. CAS: 366789-02-8
Synonyms: BAY 59-7939
Target:  

Factor Xa

Áreas de investigación:  

Cardiovascular Disease Cancer

Rivaroxaban (BAY 59-7939) is a highly potent, selective and direct Factor Xa (FXa) inhibitor, achieving a strong gain in anti-FXa potency (IC50 0.7 nM; Ki 0.4 nM) .
loading...
    loading...
10
10 Cited Publications
Referencia número: HY-10264
No. CAS: 480449-70-5
Pureza:  99.81%
Synonyms: DU-176
Target:  

Factor Xa Thrombin

Áreas de investigación:  

Cardiovascular Disease Cancer

Edoxaban (DU-176b) is an orally active, highly potent, selective, and direct Factor Xa (FXa) inhibitor with Ki values of 0.561 and 2.98 nM for free human FXa and prothrombinase. Edoxaban exhibits more than 10,000-fold selectivity over other coagulation proteases. Edoxaban can be used in preventing thromboembolic disease research .
loading...
    loading...
10
10 Cited Publications
Referencia número: HY-10264A
No. CAS: 480449-71-6
Pureza:  99.84%
Synonyms: DU-176b
Target:  

Factor Xa Thrombin

Áreas de investigación:  

Cardiovascular Disease Cancer

Edoxaban (DU-176b) tosylate is an orally active, highly potent, selective, and direct Factor Xa (FXa) inhibitor with Kis of 0.561 and 2.98 nM for free human FXa and prothrombinase. Edoxaban tosylate exhibits more than 10,000-fold selectivity over other coagulation proteases. Edoxaban tosylate can be used for preventing thromboembolic disease research .
loading...
    loading...
10
10 Cited Publications
Referencia número: HY-10264B
No. CAS: 1229194-11-9
Pureza:  99.97%
Synonyms: DU-176b monohydrate
Target:  

Factor Xa Thrombin

Áreas de investigación:  

Cardiovascular Disease Cancer

Edoxaban (DU-176b) monohydrate is an orally active, highly potent, selective, and direct Factor Xa (FXa) inhibitor with Kis of 0.561 and 2.98 nM for free human FXa and prothrombinase. Edoxaban monohydrate exhibits more than 10,000-fold selectivity over other coagulation proteases. Edoxaban monohydrate can be used for preventing thromboembolic disease research .
loading...
    loading...
5
5 Cited Publications
Referencia número: HY-10268
No. CAS: 330942-05-7
Pureza:  98.02%
Synonyms: PRT054021
Target:  

Factor Xa

Áreas de investigación:  

Cardiovascular Disease

Betrixaban (PRT054021) is a highly potent, selective, and orally efficacious factor Xa (fXa) inhibitor with an IC50 of 1.5 nM. Betrixaban shows antithrombotic effect .
loading...
    loading...
5
5 Cited Publications
Referencia número: HY-10268A
No. CAS: 936539-80-9
Pureza:  99.78%
Synonyms: PRT054021 maleate
Target:  

Factor Xa

Áreas de investigación:  

Cardiovascular Disease

Betrixaban (PRT054021) maleate is a highly potent, selective, and orally efficacious factor Xa (fXa) inhibitor with an IC50 of 1.5 nM. Betrixaban maleate shows antithrombotic effect .
loading...
    loading...
2
2 Cited Publications
Referencia número: HY-50903S
No. CAS: 1132681-38-9
Synonyms: BAY 59-7939-d4
Rivaroxaban-d4 (BAY 59-7939-d4) is a deuterium labeled Rivaroxaban. Rivaroxaban is a highly potent,selective and direct Factor Xa (FXa) inhibitor, achieving a strong gain in anti-FXa potency (IC50 0.7 nM; Ki 0.4 nM) .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-P99283
No. CAS: 1312299-39-0
Synonyms: NN 7415; mAb 2021; Anti-TFPI Recombinant Antibody

Target:  

Factor Xa

Áreas de investigación:  

Others

Concizumab is an anti-TFPI monoclonal antibody (IgG4 type) that binds to the Kunitz-type protease inhibitor (KPI) 2 structural domain of TFPI, thereby blocking the interaction of this structural domain with the FXa active site. Concizumab can be used in the study of haemophilia .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-70035
No. CAS: 193153-04-7
Synonyms: FXV673
Target:  

Factor Xa

Áreas de investigación:  

Cardiovascular Disease

Otamixaban(FXV673) is a potent (Ki = 0.5 nM), selective, rapid acting, competitive and reversible fXa inhibitor that effectively inhibits both free and prothrombinase-bound fXa.
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-P2008
No. CAS: 65147-06-0
Synonyms: IEGR-AMC
Target:  

Factor Xa

Áreas de investigación:  

Cardiovascular Disease

Boc-Ile-Glu-Gly-Arg-AMC (IEGR-AMC) is an activated factor X (FXa) specific fluorogenic peptide substrate used for Factor VIII determination .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-N2082
No. CAS: 6743-92-6
Synonyms: Cacticin
Isorhamnetin 3-O-galactoside (Cacticin) is a flavonoid glycoside that can be isolated from Oenanthe javanica, with antithrombotic and profibrinolytic activities. Isorhamnetin 3-O-galactoside inhibits the activities of thrombin and factor Xa (FXa) and reduces thrombin-catalyzed fibrin polymerization maximum rate. Isorhamnetin 3-O-galactoside suppresses TNF-α-induced PAI-1 secretion, decreases the PAI-1/tissue-type plasminogen activator (t-PA) ratio, and inhibits FXa production and FVa/FXa-mediated thrombin generation. Isorhamnetin 3-O-galactoside exerts protective effects against Carbon tetrachloride (CCl4) (HY-Y0298)-induced hepatic injury in mice. Isorhamnetin 3-O-galactoside can be used for the study of liver injury-related diseases and thrombotic vascular diseases .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-76948
No. CAS: 865479-71-6
Target:  

Factor Xa

Áreas de investigación:  

Cardiovascular Disease

5-R-Rivaroxaban is (R)-enantiomer of Rivaroxaban. Rivaroxaban (BAY 59-7939) is a highly potent and selective, direct Factor Xa (FXa) inhibitor, achieving a strong gain in anti-FXa potency (IC50 0.7 nM; Ki 0.4 nM).
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-P7860
Pureza:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: F10; Prothrombinase; Coagulation Factor X; Factor Xa; Stuart-Prower Factor; Factor X; Stuart Factor; FXa; FX
Species:  
Human
Source:  
HEK293
loading...
    loading...
Referencia número: HY-W001294
No. CAS: 109431-87-0
Áreas de investigación:  

Cardiovascular Disease

(R)-(-)-N-Boc-3-pyrrolidinol is a chiral pyrrolidine derivative. After undergoing configuration inversion via the Mitsunobu reaction, (R)-(-)-N-Boc-3-pyrrolidinol can serve as a precursor for the (3S)-aryloxypyrrolidine fragment, which is used to construct key intermediates of FXa inhibitors (such as DX-9065a (HY-10722)) and various chiral drugs. (R)-(-)-N-Boc-3-pyrrolidinol can be applied in studies related to arrhythmia .
loading...
    loading...
Referencia número: HY-50903R
No. CAS: 366789-02-8
Synonyms: BAY 59-7939 (Standard)
Áreas de investigación:  

Cardiovascular Disease Cancer

Rivaroxaban (Standard) is the analytical standard of Rivaroxaban. This product is intended for research and analytical applications. Rivaroxaban (BAY 59-7939) is a highly potent, selective and direct Factor Xa (FXa) inhibitor, achieving a strong gain in anti-FXa potency (IC50 0.7 nM; Ki 0.4 nM) .
loading...
    loading...
Referencia número: HY-10264S
No. CAS: 1304701-57-2
Pureza:  ≥99.0%
Synonyms: DU-176-d6
Edoxaban-d6 is deuterium labeled Edoxaban. Edoxaban (DU-176) is a selective, potent and orally active factor Xa (FXa) inhibitor with Kis of 0.561 nM and 2.98 nM for free FXa and prothrombinase, respectively. Edoxaban is an anticoagulant agent and can be used for stroke prevention. Edoxaban is also a weak inhibitor of thrombin and factor IXaβ (FIXa), with Kis of 6.00 μM and 41.7 μM, respectively, exhibits >10000-fold selectivity for FXa. Edoxaban has antithrombotic properties and has potential for thromboembolic diseases treatment .
loading...
    loading...
Referencia número: HY-75680
No. CAS: 503614-91-3
Target:  

Factor Xa

Áreas de investigación:  

Cardiovascular Disease

Apixaban ethyl ester is a key intermediate in the synthesis of FXa inhibitors, which is used to study the inhibitory activity against venous thrombosis .
loading...
    loading...
Referencia número: HY-10264R
No. CAS: 480449-70-5
Synonyms: DU-176 (Standard)
Áreas de investigación:  

Cardiovascular Disease Cancer

Edoxaban (Standard) is the analytical standard of Edoxaban. This product is intended for research and analytical applications. Edoxaban (DU-176b) is an orally active, highly potent, selective, and direct Factor Xa (FXa) inhibitor with Ki values of 0.561 and 2.98 nM for free human FXa and prothrombinase. Edoxaban exhibits more than 10,000-fold selectivity over other coagulation proteases. Edoxaban can be used in preventing thromboembolic disease research .
loading...
    loading...
Referencia número: HY-134686
No. CAS: 480452-36-6
Pureza:  99.08%
Target:  

Factor Xa Thrombin

Áreas de investigación:  

Cardiovascular Disease

Edoxaban impurity 4 is an impurity of Edoxaban. Edoxaban (DU-176) is a selective, potent and orally active factor Xa (FXa) inhibitor with Kis of 0.561 nM and 2.98 nM for free FXa and prothrombinase, respectively. Edoxaban is an anticoagulant agent and can be used for stroke prevention .
loading...
    loading...
Referencia número: HY-10267
No. CAS: 536748-46-6
Pureza:  98.52%
Synonyms: PD-0348292
Target:  

Factor Xa

Áreas de investigación:  

Cardiovascular Disease

Eribaxaban (PD-0348292) is an orally active and selective FXa inhibitor with a Ki value of 0.32 nM. Eribaxaban reduces thrombus formation .
loading...
    loading...